CACNA1D and colorectal carcinoma: This study demonstrates that the first-line antihypertensive NTD arrested the progression of CRC by suppressing cell proliferation and migration and revealed synergistic activity with the commonly used chemotherapy drug OXA by downregulating CACNA1D.